GNPX

NASDAQ 已收盘

Genprex

1.45 USD
▼-0.22-13.17%
盘后 1.45 0.00%
2026-11-20
市值
$1.19M
市盈率
—
EPS
-40.08
股息率
—
52 周区间
1.45 – 80.96
成交量
93.67K
Beta
-0.99
目标价
—
52W 低 1.4552W 高 80.96
价格走势

公司简介

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is bei...